Guidance for Abiomed Inc. (ABMD)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2023 | N/A | N/A | $1.14B – 1.18B | $1.17B | = Maintained | Details |
2022 | N/A | N/A | $1.01B – 1.03B | $1.04B | = Maintained | Details |
2022 | N/A | N/A | $0.99B – 1.03B | $1.00B | = Maintained | Details |
2022 | N/A | N/A | $1.03B – 1.03B | $1.02B | Raised | Details |
Q4 2021 | N/A | N/A | $225.00M – 235.00M | $230.96M | = Maintained | Details |
Q3 2021 | N/A | N/A | $221.00M – 230.00M | $235.10M | = Maintained | Details |
2020 | N/A | N/A | $885.00M – 925.00M | $927.10M | Lowered | Details |
2020 | N/A | N/A | $846.00M – 877.00M | N/A | = Maintained | Details |
2020 | N/A | N/A | $885.00M – 925.00M | $895.00M | = Maintained | Details |
2019 | N/A | N/A | $740.00M – 770.00M | $747.30M | = Maintained | Details |
2019 | N/A | N/A | $775.00M – 790.00M | $768.10M | = Maintained | Details |
2019 | N/A | N/A | $765.00M – 770.00M | $770.52M | = Maintained | Details |
2018 | N/A | N/A | $560.00M – 575.00M | $570.40M | = Maintained | Details |
Q4 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
2017 | N/A | N/A | $435.00M – 445.00M | $446.33M | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2015 | N/A | N/A | $300.00M – 310.00M | $292.40M | Raised | Details |
2014 | N/A | N/A | $180.00M – 185.00M | $180.78M | = Maintained | Details |
2014 | N/A | N/A | $209.00M – 212.00M | $207.80M | Raised | Details |
2014 | N/A | N/A | $180.00M – 185.00M | $183.63M | = Maintained | Details |
2013 | N/A | N/A | $180.00M – 185.00M | $183.80M | = Maintained | Details |
2012 | N/A | N/A | $120.00M – 125.00M | $119.36M | = Maintained | Details |
2012 | N/A | N/A | $122.00M – 125.00M | $123.30M | Raised | Details |
2011 | $99.00 – $101.00 | $94.77 | N/A | N/A | = Maintained | Details |